Cancer Drug for Alzheimer's Treatment Greensboro NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Charles Keith Willis
(336) 273-2511
1126 N Church St
Greensboro, NC
Specialty
Neurology

Data Provided by:
Kyle L Cabbell, MD
(336) 272-4578
1313 Carolina St Ste 300
Greensboro, NC
Specialties
Neurological Surgery
Gender
Male
Education
Graduation Year: 1992

Data Provided by:
Robert Wayne Nudelman
(336) 272-4578
1313 Carolina St
Greensboro, NC
Specialty
Neurosurgery

Data Provided by:
Michael Leroy Reynolds
(336) 273-2511
1126 N Church St
Greensboro, NC
Specialty
Neurology

Data Provided by:
Carmen Dohmeier
(336) 273-2511
1126 N Church St
Greensboro, NC
Specialty
Neurology

Data Provided by:
James U Adelman, MD
(336) 547-8000
301 E Wendover Ave Ste 411
Greensboro, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Northwestern Univ Med Sch, Chicago Il 60611
Graduation Year: 1967
Hospital
Hospital: Wesley Long Community Hospital, Greensboro, Nc
Group Practice: Emg/Eeg Consultants

Data Provided by:
James Ronald Hirsch, MD
(336) 272-4578
1313 Carolina St Ste 300
Greensboro, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Med Coll Of Wi, Milwaukee Wi 53226
Graduation Year: 1992
Hospital
Hospital: Moses H Cone Memorial Hospital, Greensboro, Nc; Wesley Long Community Hospital, Greensboro, Nc
Group Practice: Guilford Neurosurgical Associates

Data Provided by:
James Ronald Hirsch
(336) 272-4578
1313 Carolina St
Greensboro, NC
Specialty
Neurosurgery

Data Provided by:
Syed Tajul Arfeen
(336) 832-9600
700 Walter Reed Dr
Greensboro, NC
Specialty
Neurology

Data Provided by:
Dr.Jeffrey Jenkins
(336) 272-4578
1130 N Church St # 200
Greensboro, NC
Gender
M
Education
Medical School: Temple Univ Sch Of Med
Year of Graduation: 1991
Speciality
Neurosurgeon
General Information
Accepting New Patients: Yes
RateMD Rating
1.0, out of 5 based on 2, reviews.

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com